Clinical trial · Interventional
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
Nanocytology Evaluation of Epidermal Cells to Assess Risk of Squamous Cell Carcinoma and Field Cancerization in High Risk Patients
NCT01905891CI-TRIAL-00016104completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to correlate pathological features from specimens in order to determine if this new molecular diagnostic technique can be used to detect risk of skin cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Actinic Keratosis | — | UNRESOLVED | — |
| Squamous Cell Carcinoma | Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Superficial shave biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Subjects at risk of skin cancer
- description
- Subjects at risk of skin cancer (sun-damaged skin) a superficial shave biopsy will be performed.
- interventionNames
- Procedure: Superficial shave biopsy
- type
- OTHER
- label
- Subjects with healthy skin
- description
- Subjects without sun-damaged skin a superficial shave biopsy will be performed.
- interventionNames
- Procedure: Superficial shave biopsy
Primary outcomes (1)
- measure
- Nanocytology assessment of skin cancer risk
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 89 Years
Show eligibility criteria text
Inclusion Criteria: * 18 to 89 years old, male and female, Fitzpatrick skin phototype I - III * Photodamage skin grades 3 - 4 (global assessment) * Medical history of precancerous lesions and or known history of SCC or healthy volunteers Exclusion Criteria: * Subjects under 18 years old * Pregnant women or lactating mothers * Treatment with systemic chemotherapy within 4 weeks period before consent * Known HIV+ patients (self-reported)
References
Publications (0)
Data not yet available
No reference posted for this study.